Find policies, billing codes, payers, states, and providers

CPT 81493: 23-Gene RT-PCR Test with Algorithmic CAD Risk Score

CPT code 81493 represents a molecular diagnostic service that uses real-time PCR on peripheral blood to assay 23 genes and applies an algorithmic analysis to generate a coronary artery disease (CAD) risk score. As precision medicine and genomic risk stratification expand in cardiology, this code captures a combined laboratory and analytic service that influences diagnostic pathways and preventive care strategies at a national level.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for gene-based CAD risk scoring, how payers approach coverage for combined analytic-laboratory services, and benchmark information on typical sites of service and service type. The publication outlines coding implications, common modifiers used with lab and analytic services, and the operational setting for performing the assay.

This summary provides clinicians, billing professionals, and policy analysts a concise reference to understand what CPT code 81493 denotes, its role in CAD risk assessment, and the payer landscape relevant to adoption and reimbursement of gene-based algorithmic risk scores.

Customize your policy alerts

Sign up for cpt 81493 policy alerts

Get alerted when payer policies referencing 81493 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

CPT code 81493 describes a laboratory service in which a lab analyst performs real-time polymerase chain reaction (RT-PCR) testing on peripheral blood targeting 23 genes, and then applies an algorithmic analysis that combines the molecular test results with patient data to produce a patient risk score for coronary artery disease (CAD).

Service type: Molecular diagnostic assay with algorithmic risk-scoring (laboratory-developed test / in vitro diagnostic workflow)
Typical site of service: Clinical laboratory or reference lab with molecular diagnostics capability; specimen collected from peripheral blood.

Find policies, billing codes, payers, states, and providers

CPT 81493: 23-Gene RT-PCR Test with Algorithmic CAD Risk Score

Customize your policy alerts

Sign up for cpt 81493 policy alerts

Get alerted when payer policies referencing 81493 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

Service type: Molecular diagnostic assay with algorithmic risk-scoring (laboratory-developed test / in vitro diagnostic workflow)
Typical site of service: Clinical laboratory or reference lab with molecular diagnostics capability; specimen collected from peripheral blood.

Clinical & Coding Specifications

Clinical Context

A 58-year-old male with intermediate cardiovascular risk is referred by his primary care clinician for genetic risk stratification for coronary artery disease (CAD). He has a family history of premature CAD (father had an MI at 52), borderline hyperlipidemia on lifestyle therapy, and well-controlled hypertension. The clinician orders a blood-based genomic test that analyzes variants across a multi-gene panel and integrates results with clinical data to generate a patient-specific CAD risk score.

In the clinical workflow: the patient presents to an ambulatory phlebotomy or specialty laboratory collection site where peripheral blood is drawn. The specimen is sent to a CLIA-certified molecular laboratory. A lab analyst performs real-time polymerase chain reaction (RT-PCR) assays for the 23-gene panel, runs internal quality controls, and transfers raw data into the laboratory’s validated algorithm. The algorithm combines genotypic results with supplied clinical variables (age, sex, lipid values, smoking status, etc.) to compute a numerical and categorical CAD risk score. The laboratory issues a finalized report to the ordering clinician. The ordering clinician uses the report to inform shared decision-making about preventive therapy, additional testing, or referral to cardiology.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component if separated from the technical lab component.
`TC`	Technical component	Use when billing only the technical component (laboratory testing) of the service.
`90`	Reference (outside) laboratory	Use when the testing was performed by an outside laboratory and results are being reported by the billing provider.
`91`	(not in provided list)	Data not available in the input.
`52`	Reduced services	Use when the lab test or algorithmic analysis was partially performed or limited for documented reasons.
`53`	Discontinued procedure	Use if specimen collection or testing was started but discontinued for documented patient or technical reasons.
`59`	(not in provided list)	Data not available in the input.
`62`	Two surgeons	Not typically applicable but used when two qualified providers share a single procedure; rarely used for consultative genetic services.
`80`	Assistant surgeon	Typically not applicable to laboratory testing; included when an assistant is necessary for an associated invasive collection procedure.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services	Use when an advanced practice clinician bills for ordering or interpreting components per payer rules.
`QX`	Ordering physician attests to supervising clinical staff	Use when applicable for molecular pathology services supervised per laboratory/payer policies.
`QY`	Clinical staff provided the non-physician practitioner services under physician supervision	Use when applicable per local supervisory documentation.
`QK`	Medical director or QHP billing for supervisory services	Use when a laboratory medical director bills for supervisory oversight of testing.
`22`	Increased procedural services	Use when reporting additional work or complexity in test performance or interpretation beyond typical service.

Taxonomy Code	Specialty	Notes
207Q00000X	Clinical Molecular Genetics Laboratory	Laboratory specialists performing molecular testing and algorithmic analysis.
207L00000X	Pathology	Pathologists overseeing molecular diagnostics and result interpretation.
207RP1001X	Clinical Pathology	Clinical pathologists responsible for laboratory quality and reporting.
363LP0800X	Laboratory Technician	Laboratory technologists or analysts performing RT-PCR testing.
208D00000X	Cardiovascular Disease	Ordering cardiologists who may interpret CAD risk reports in care planning.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Common indication for genomic CAD risk assessment to refine risk stratification and guide preventive therapy.
`I20.9`	Angina pectoris, unspecified	Used when patients with chest pain or suspected ischemia undergo further risk evaluation including genomic testing.
`E78.5`	Hyperlipidemia, unspecified	Dyslipidemia commonly coexists with genetic risk factors and is used in algorithmic risk models.
`I10`	Essential (primary) hypertension	Hypertension is a major clinical variable included when integrating genomic risk into overall CAD risk.
`Z13.6`	Encounter for screening for cardiovascular disorders	Code used for asymptomatic patients undergoing CAD risk screening with advanced testing.
`Z82.49`	Family history of ischemic heart disease and other diseases of the circulatory system	Family history drives consideration of genetic testing and risk scoring for CAD.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Specimen collection for the peripheral blood required for the genomic assay.
`81025`	Urinalysis, automated, with microscopy (if performed)	Ancillary screening test sometimes performed during cardiovascular risk workup; not required for the genomic assay.
`80061`	Lipid panel (cholesterol, HDL, triglycerides)	Clinical laboratory tests commonly ordered alongside genomic CAD risk testing to provide clinical variables for algorithmic risk calculation.
`82947`	Glucose; quantitative, blood (e.g., fasting glucose)	Metabolic data often included in cardiovascular risk assessment integrated with genomic results.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specimen collection adjuncts)	Occasionally used if pharmacologic agents are administered in conjunction with clinic procedures related to testing workflow.

CPT 81490: RA Disease Activity Score from 12-Serum Biomarker Panel

CPT-81500-CA125-HE4-ALGORITHMIC-RISK-SCORE

CPT 81500: CA-125 and HE4 Laboratory Testing with Algorithmic Risk Score

CPT-81503-ALGORITHMIC-LAB-RISK-SCORE-CA125-APOLIPOPROTEIN-A1

CPT 81503: Algorithmic Laboratory Risk Score Using Multiple Biomarkers

CPT-81504-TUMOR-ORIGIN-RNA-EXPRESSION-CLASSIFIER

CPT 81504: RNA Expression Tumor Origin Classifier

CPT-81506-DIABETES-BIOMARKER-PANEL-WITH-RISK-SCORE

CPT 81506: Diabetes Biomarker Panel with Algorithmic Risk Score

CPT-81507-NIPS-CELL-FREE-DNA-TRISOMY-RISK-ANALYSIS

CPT 81507: Non-Invasive Prenatal Screening for Trisomies 13, 18, 21

CPT-81508-PAPP-A-HCG-ALGORITHMIC-RISK-ASSAY

CPT 81508: PAPP–A and hCG Laboratory Assay with Algorithmic Risk Score

CPT-81509-LAB-ALGORITHMIC-RISK-ASSESSMENT-PAPP-A-HCG-DIA

CPT 81509: Laboratory Algorithmic Risk Assessment for PAPP–A, hCG, DIA

CPT-81510-PRENATAL-TRIPLE-MARKER-ALGORITHMIC-RISK-ASSESSMENT

CPT 81510: Prenatal Triple-Analyte Algorithmic Risk Assessment

CPT-81511-MULTIANALYTE-SERUM-SCREENING-ALGORITHMIC-RISK-SCORE

CPT 81511: Multianalyte Serum Screening with Algorithmic Risk Score

Showing 1–10 of 41

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component if separated from the technical lab component.
`TC`	Technical component	Use when billing only the technical component (laboratory testing) of the service.
`90`	Reference (outside) laboratory	Use when the testing was performed by an outside laboratory and results are being reported by the billing provider.
`91`	(not in provided list)	Data not available in the input.
`52`	Reduced services	Use when the lab test or algorithmic analysis was partially performed or limited for documented reasons.
`53`	Discontinued procedure	Use if specimen collection or testing was started but discontinued for documented patient or technical reasons.
`59`	(not in provided list)	Data not available in the input.
`62`	Two surgeons	Not typically applicable but used when two qualified providers share a single procedure; rarely used for consultative genetic services.
`80`	Assistant surgeon	Typically not applicable to laboratory testing; included when an assistant is necessary for an associated invasive collection procedure.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services	Use when an advanced practice clinician bills for ordering or interpreting components per payer rules.
`QX`	Ordering physician attests to supervising clinical staff	Use when applicable for molecular pathology services supervised per laboratory/payer policies.
`QY`	Clinical staff provided the non-physician practitioner services under physician supervision	Use when applicable per local supervisory documentation.
`QK`	Medical director or QHP billing for supervisory services	Use when a laboratory medical director bills for supervisory oversight of testing.
`22`	Increased procedural services	Use when reporting additional work or complexity in test performance or interpretation beyond typical service.

Taxonomy Code	Specialty	Notes
207Q00000X	Clinical Molecular Genetics Laboratory	Laboratory specialists performing molecular testing and algorithmic analysis.
207L00000X	Pathology	Pathologists overseeing molecular diagnostics and result interpretation.
207RP1001X	Clinical Pathology	Clinical pathologists responsible for laboratory quality and reporting.
363LP0800X	Laboratory Technician	Laboratory technologists or analysts performing RT-PCR testing.
208D00000X	Cardiovascular Disease	Ordering cardiologists who may interpret CAD risk reports in care planning.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Common indication for genomic CAD risk assessment to refine risk stratification and guide preventive therapy.
`I20.9`	Angina pectoris, unspecified	Used when patients with chest pain or suspected ischemia undergo further risk evaluation including genomic testing.
`E78.5`	Hyperlipidemia, unspecified	Dyslipidemia commonly coexists with genetic risk factors and is used in algorithmic risk models.
`I10`	Essential (primary) hypertension	Hypertension is a major clinical variable included when integrating genomic risk into overall CAD risk.
`Z13.6`	Encounter for screening for cardiovascular disorders	Code used for asymptomatic patients undergoing CAD risk screening with advanced testing.
`Z82.49`	Family history of ischemic heart disease and other diseases of the circulatory system	Family history drives consideration of genetic testing and risk scoring for CAD.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Specimen collection for the peripheral blood required for the genomic assay.
`81025`	Urinalysis, automated, with microscopy (if performed)	Ancillary screening test sometimes performed during cardiovascular risk workup; not required for the genomic assay.
`80061`	Lipid panel (cholesterol, HDL, triglycerides)	Clinical laboratory tests commonly ordered alongside genomic CAD risk testing to provide clinical variables for algorithmic risk calculation.
`82947`	Glucose; quantitative, blood (e.g., fasting glucose)	Metabolic data often included in cardiovascular risk assessment integrated with genomic results.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specimen collection adjuncts)	Occasionally used if pharmacologic agents are administered in conjunction with clinic procedures related to testing workflow.

CPT 81490: RA Disease Activity Score from 12-Serum Biomarker Panel

CPT-81500-CA125-HE4-ALGORITHMIC-RISK-SCORE

CPT 81500: CA-125 and HE4 Laboratory Testing with Algorithmic Risk Score

CPT-81503-ALGORITHMIC-LAB-RISK-SCORE-CA125-APOLIPOPROTEIN-A1

CPT 81503: Algorithmic Laboratory Risk Score Using Multiple Biomarkers

CPT-81504-TUMOR-ORIGIN-RNA-EXPRESSION-CLASSIFIER

CPT 81504: RNA Expression Tumor Origin Classifier

CPT-81506-DIABETES-BIOMARKER-PANEL-WITH-RISK-SCORE

CPT 81506: Diabetes Biomarker Panel with Algorithmic Risk Score

CPT-81507-NIPS-CELL-FREE-DNA-TRISOMY-RISK-ANALYSIS

CPT 81507: Non-Invasive Prenatal Screening for Trisomies 13, 18, 21

CPT-81508-PAPP-A-HCG-ALGORITHMIC-RISK-ASSAY

CPT 81508: PAPP–A and hCG Laboratory Assay with Algorithmic Risk Score

CPT-81509-LAB-ALGORITHMIC-RISK-ASSESSMENT-PAPP-A-HCG-DIA

CPT 81509: Laboratory Algorithmic Risk Assessment for PAPP–A, hCG, DIA

CPT-81510-PRENATAL-TRIPLE-MARKER-ALGORITHMIC-RISK-ASSESSMENT

CPT 81510: Prenatal Triple-Analyte Algorithmic Risk Assessment

CPT-81511-MULTIANALYTE-SERUM-SCREENING-ALGORITHMIC-RISK-SCORE

CPT 81511: Multianalyte Serum Screening with Algorithmic Risk Score

Showing 1–10 of 41

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

CPT 81493: 23-Gene RT-PCR Test with Algorithmic CAD Risk Score

Sign up for cpt 81493 policy alerts

Billing Code Overview

Catch payer policy changes before they impact reimbursement

Catch payer policy changes before they impact reimbursement

OpenPayer

CPT 81493: 23-Gene RT-PCR Test with Algorithmic CAD Risk Score

Sign up for cpt 81493 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References